SCHEMBL20008366

SCHEMBL20008366

N#CB1CCC(O)(CN)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23288603 0.76 — —
SCHEMBL20008099 0.76 — —
SCHEMBL21088130 0.74 — —
SCHEMBL291596 0.69 — —
Hydrochloric Acid SCHEMBL22615270 0.67 — —
SCHEMBL20007956 0.65 ALDH1A1 (0.33) —
SCHEMBL21287129 0.65 MAOA (0.61) —
SCHEMBL842096 0.65 — —
SCHEMBL944236 0.65 — —
SCHEMBL4442509 0.63 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515916-B1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS INC (US) 2023-06-07 — — EP disclosed
WO-2018057884-A1 SHP2 PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2018-03-29 — — WO disclosed
Send feedback